Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients

BACKGROUND: The incidence of colorectal cancer (CRC) is expected to increase by 80% in year 2035. Even though advantages in treatment of CRC have being made over the last decades, the outcome remains poor. Recently, several inflammatory markers including pretreatment neutrophil to lymphocyte ratio (...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimitriou, Nikoletta, Felekouras, Evangelos, Karavokyros, Ioannis, Alexandrou, Andreas, Pikoulis, Emmanuel, Griniatsos, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278137/
https://www.ncbi.nlm.nih.gov/pubmed/30509242
http://dx.doi.org/10.1186/s12885-018-5042-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278137/
https://www.ncbi.nlm.nih.gov/pubmed/30509242
http://dx.doi.org/10.1186/s12885-018-5042-x

Ejemplares similares